Stress, Type 1 Diabetes
Conditions
Keywords
Type 1 diabetes, Children and adolescents, Stress, Genetic factors, Psychological background
Brief summary
The aims of this study are two fold: To show whether there is an increased environmental or genetic susceptibility to stress in patients with T1D and whether it influences diabetes management. And to develop a strategy for the assessment and treatment of patients with T1D and an increased risk for development of psychopathology under stress.
Detailed description
Lately, a marked increase in the incidence and earlier age of onset of type 1 diabetes (T1D) has been noted. These observations could also be connected to an increased prevalence of stressful experiences and a lowered stress tolerance in some children. The way a person responds to stress is determined by the interplay of genetic and environmental factors. Environmental experiences at specific times of development have been shown to shape individual's hypothalamic-pituitary-adrenal axis (HPA axis) stress response. It is known, that early development of central nervous system is critically dependent on child's interaction with the environment (experience dependent maturation), especially to the attachment to caregivers (most often the mother). Appropriate caregiving is connected to lower basal cortisol levels in children and a more stable HPA axis response after the exposure to stress. Any circumstances that disturbed the formation of the attachment to the primary caregiver (e.g. complications at delivery, psychosocial stressors affecting the mother or mother's postpartum depression) resulted in higher HPA axis responsiveness to stress in the affected children. Changes in individual genes have also been shown to influence a person's susceptibility to stress and risk for the development of stress-induced psychopathology.
Interventions
BEHAVIORALPsychological background determinations
For the psychological background determinations a structured interview and questionnaires will be administered: 1. Child Attachment Interview (CAI) 2. General/sociodemographic questionnaire with the questions on diabetes management, current health status and the child's development in the infancy 3. Parenting Stress Index with the 19-item Life Stress Scale (PSI) 4. Achenbach System of Empirically Based Assessment (CBCL, YSR) 5. Holmes and Rahe Social readjustment rating scale 6. Lifetime Incidence of Traumatic Events (LITE) - parent and child reports of child's trauma/loss history (LITE- S/ P) 7. Experiences in Close Relationships - Relationship Structures questionnaire (ECR-RS)
GENETICGenetic susceptibility determination
DNA will be isolated from the patients' blood samples and form the control subjects buccal swabs. The genes with expected influence to stress reactivity and mental disorders will be tested.
PROCEDURECortisol release test
Synacthen test - will be used with the group of patients with type 1 diabetes to measure HPA axis reactivity
PROCEDURESaliva cortisol measurement
Saliva cortisol measurement - will be used with the patients before and after the Synacthen test and with the Hashimoto thyroiditis and the healthy control group before and after the Child Attachment Interview
Sponsors
University of Ljubljana, Faculty of Medicine
Study design
Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
8 Years to 15 Years
Healthy volunteers
Yes
Inclusion criteria
* Informed consent signed by a parent/legal guardian and informed assent signed by the study participant prior study entry * Diagnosed with Type 1 DM prior to signature of Patient Informed Consent (PIC) (for the T1D group). * Age between 8-15 years old (inclusive) at signature of PIC * Treated by the investigator's centre prior signature of PIC (For the T1D group). * Willing to undergo all study procedures
Exclusion criteria
* Any documented concomitant chronic disease known to affect diabetes control (e.g. altered renal function, active cancer undergoing treatment, Crohn's disease, ulcerative colitis, Mb Addison disease) * Any other medical, social or psychological condition that, in the investigator's opinion, makes the patient unable to comply with the study protocol (e.g. intellectual disability).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Significant between group differences in metabolic control | 1 month | Association between psychological scores, stress reactivity, genetic factors and metabolic control in patients with type 1 diabetes |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Significant differences in psychological scores between groups | 1 week | Significant differences in psychological scores between the patients with type 1 diabetes and the control group |
Countries
Slovenia
Outcome results
None listed